Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies
暂无分享,去创建一个
A. Windhorst | N. Devoogdt | Q. Lecocq | K. Breckpot | T. Lahoutte | F. Bruchertseifer | M. Keyaerts | P. Debie | F. van der Aa | J. Puttemans | Heleen Hanssens | A. Morgenstern | J. Eersels | M. D'Huyvetter | Yana Dekempeneer